Please assess the completion status of the following clinical trial:

Trial Title: Individualized Treatment of Patients With Chronic Tinnitus With Repetitive Transcranial Magnetic Stimulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* chronic tinnitus (\> 6 months)~* at least moderate tinnitus distress~* no or consistent medication~* no or consistent Treatments~* residence in Germany and German speaking~Exclusion Criteria:~* objective tinnitus~* serious and not stable illness (e.g. acute psychosis, severe depression or substance dependence, epilepsy, brain tumor)~* meeting the contraindications for transcranial magnetic stimulation or magnetic resonance imaging (electric devices or metal implants in the body, e.g. cardiac pace maker, insulin pump)~* neurological disorders (e.g. cerebrovascular events, neurodegenerative disorder, epilepsy, brain malformation, severe head trauma)~* addictive disorder with consumption in the last two years~* regular intake of benzodiazepines~* participation in another study parallel to the trial~* pregnancy or breastfeeding period~* psychiatric confinement

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- individualized rTMS (Type: EXPERIMENTAL): Treatment with the best (highest reduction in tinnitus loudness, most reliable, superior to control condition, most tolerable) protocol as obtained in the test sessions (left vs. right temporoparietal junction, 1Hz, 10Hz, 20Hz, 0.1Hz as active control condition).
- standard rTMS in responders (Type: ACTIVE_COMPARATOR): Treatment with standard protocol: left-sided 1Hz in the group of patients who showed temporary reductions in tinnitus loudness in test sessions.
- standard rTMS in non-responders (Type: ACTIVE_COMPARATOR): Treatment with standard protocol: left-sided 1Hz in the group of patients who did not show temporary reductions in tinnitus loudness in test sessions.

Based on this trial design, predict the completion outcome and termination type (if applicable).